Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 260

1.

The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).

Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A.

Acta Diabetol. 2012 Dec;49 Suppl 1:S153-60. doi: 10.1007/s00592-012-0391-4. Epub 2012 Apr 1.

PMID:
22466072
[PubMed - indexed for MEDLINE]
2.

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.

Sartore G, Chilelli NC, Burlina S, Lapolla A.

Acta Diabetol. 2013 Jun;50(3):437-42. doi: 10.1007/s00592-013-0459-9. Epub 2013 Feb 16.

PMID:
23417155
[PubMed - indexed for MEDLINE]
3.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
[PubMed - indexed for MEDLINE]
4.

Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.

Zucchini S, Scipione M, Balsamo C, Maltoni G, Rollo A, Molinari E, Mangoni L, Cicognani A.

Diabetes Technol Ther. 2011 Dec;13(12):1187-93. doi: 10.1089/dia.2011.0080. Epub 2011 Aug 19.

PMID:
21854193
[PubMed - indexed for MEDLINE]
5.
6.

Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.

Kim MJ, Jung HS, Hwang-Bo Y, Cho SW, Jang HC, Kim SY, Park KS.

Acta Diabetol. 2013 Aug;50(4):505-10. doi: 10.1007/s00592-011-0302-0. Epub 2011 Jun 18.

PMID:
21688018
[PubMed - indexed for MEDLINE]
7.

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

Diabetes Technol Ther. 2005 Aug;7(4):587-96.

PMID:
16120030
[PubMed - indexed for MEDLINE]
8.

Analysis of 24-hour glycemic excursions in patients with type 1 diabetes by using continuous glucose monitoring.

Taki K, Nishimura R, Morimoto A, Tsujino D, Miyashita Y, Tajima N.

Diabetes Technol Ther. 2010 Jul;12(7):523-8. doi: 10.1089/dia.2009.0167.

PMID:
20597826
[PubMed - indexed for MEDLINE]
9.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
[PubMed - indexed for MEDLINE]
Free Article
10.

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Review.

PMID:
22209014
[PubMed - indexed for MEDLINE]
11.

The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes.

Johnson SL, McEwen LN, Newton CA, Martin CL, Raskin P, Halter JB, Herman WH.

J Diabetes Complications. 2011 Jul-Aug;25(4):211-5. doi: 10.1016/j.jdiacomp.2010.09.005. Epub 2010 Nov 9.

PMID:
21062674
[PubMed - indexed for MEDLINE]
12.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
[PubMed - indexed for MEDLINE]
13.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
[PubMed - indexed for MEDLINE]
14.

Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.

Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon MK, Chin SO, Rhee SY, Oh S, Kim YS, Woo JT.

Diabetes Technol Ther. 2013 Jun;15(6):455-60. doi: 10.1089/dia.2012.0315. Epub 2013 Apr 25.

PMID:
23617251
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.

Peña NV, Torres M, Cardona JA, Iniesta R.

Diabetes Technol Ther. 2013 Feb;15(2):136-42. doi: 10.1089/dia.2012.0243. Epub 2013 Jan 5.

PMID:
23289433
[PubMed - indexed for MEDLINE]
16.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.

PMID:
19767384
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.

Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.

Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.

PMID:
21883672
[PubMed - indexed for MEDLINE]
18.

Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.

Rodbard D, Jovanovic L, Garg SK.

Diabetes Technol Ther. 2009 Dec;11(12):757-65. doi: 10.1089/dia.2009.0078.

PMID:
20001676
[PubMed - indexed for MEDLINE]
19.

Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus.

Alemzadeh R, Loppnow C, Parton E, Kirby M.

Diabetes Technol Ther. 2003;5(2):167-73.

PMID:
12871606
[PubMed - indexed for MEDLINE]
20.

Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.

Bao YQ, Zhou J, Zhou M, Cheng YJ, Lu W, Pan XP, Tang JL, Lu HJ, Jia WP.

Clin Exp Pharmacol Physiol. 2010 May;37(5-6):564-8. doi: 10.1111/j.1440-1681.2010.05361.x. Epub 2010 Jan 17.

PMID:
20082624
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk